[18F]APN-1607
wf-[18F]APN-1607
Phase 1 small_molecule active
Quick answer
[18F]APN-1607 for Alzheimer Disease is a Phase 1 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Alzheimer Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active